Authors : Tsuji Y; Department of Medical Pharmaceutics, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan.; Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*pharmacology ; Blood Platelets/Blood Platelets/Blood Platelets/*drug effects ; Bone Marrow/Bone Marrow/Bone Marrow/*drug effects

Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2017 Aug; Vol. 83 (8), pp. 1758-1772. Date of Electronic Publication: 2017 Mar 31.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?

Authors : Pea F; Institute of Clinical Pharmacology, Azienda Ospedaliero-Universitaria Santa Maria Della Misericordia, Udine.; Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy.

Subjects: Precision Medicine* ; Quality Indicators, Health Care*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use

Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 Feb; Vol. 81 (2), pp. 341-8. Date of Electronic Publication: 2015 Dec 05.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list

Academic Journal

Clinical research for saliva‐based therapeutic drug monitoring of linezolid.

Authors : Inoue, Yuki¹ (AUTHOR); Kashiwagi, Hitoshi² (AUTHOR); Sato, Yuki² (AUTHOR)

Subjects: *DRUG monitoring; *LINEZOLID; *INTRAVENOUS therapy

Source: British Journal of Clinical Pharmacology. Oct2024, p1. 7p. 3 Illustrations.

Record details

Read More Add to Saved list

Academic Journal

Model‐based dose optimization framework for bedaquiline, pretomanid and linezolid for the treatment of drug‐resistant tuberculosis.

Authors : Mehta, Krina; Guo, Tingjie; van der Graaf, Piet H.

Subjects: LINEZOLID; TUBERCULOSIS; MYCOBACTERIUM tuberculosis

Source: British Journal of Clinical Pharmacology; Feb2024, Vol. 90 Issue 2, p463-474, 12p

Record details

Read More Add to Saved list

Academic Journal

Effect of renal function on the risk of thrombocytopaenia in patients receiving linezolid therapy: A systematic review and meta‐analysis.

Authors : Shi, Changcheng; Xia, Junbo; Ye, Jian

Subjects: RANDOM effects model; KIDNEY physiology; LINEZOLID

Source: British Journal of Clinical Pharmacology; Feb2022, Vol. 88 Issue 2, p464-475, 12p

Record details

Read More Add to Saved list

Academic Journal

Population pharmacokinetics and target attainment analysis of linezolid in multidrug‐resistant tuberculosis patients.

Authors : Tietjen, Anna K.; Kroemer, Niklas; Cattaneo, Dario

Subjects: MULTIDRUG-resistant tuberculosis; TUBERCULOSIS; LINEZOLID

Source: British Journal of Clinical Pharmacology; Apr2022, Vol. 88 Issue 4, p1835-1844, 10p

Record details

Read More Add to Saved list

Academic Journal

Parametric population pharmacokinetics of linezolid: A systematic review.

Authors : Qin, Yan; Zhang, Li‐Li; Ye, Yan‐Rong

Subjects: LINEZOLID; PHARMACOKINETICS; CHILD patients

Source: British Journal of Clinical Pharmacology; Sep2022, Vol. 88 Issue 9, p4043-4066, 24p

Record details

Read More Add to Saved list

Academic Journal

Linezolid and the risk of QT interval prolongation: A pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System.

Authors : Haixia Shao; Dawei Shi; Ying Dai

Subjects: LINEZOLID; ARRHYTHMIA; LONG QT syndrome

Source: British Journal of Clinical Pharmacology; Apr2023, Vol. 89 Issue 4, p1386-1392, 7p

Record details

Read More Add to Saved list

Academic Journal

Drug‐induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis.

Authors : He, Qingfeng¹ (AUTHOR); Li, Yang² (AUTHOR); Liu, Sifan¹ (AUTHOR)

Subjects: *ANTITUBERCULAR agents; *DATABASES; *LINEZOLID

Source: British Journal of Clinical Pharmacology. Oct2024, p1. 9p. 2 Illustrations.

Record details

Read More Add to Saved list

Academic Journal

Effect of oral linezolid on the pressor response to intravenous tyramine.

Authors : Cantarini, Mireille V.; Painter, Catherine J.; Gilmore, Elaine M.

Subjects: MONOAMINE oxidase; TYRAMINE; MOCLOBEMIDE

Source: British Journal of Clinical Pharmacology; Nov2004, Vol. 58 Issue 5, p470-475, 6p

Record details

Read More Add to Saved list

menu

Search Results

Your Filters

Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients.

A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?

Clinical research for saliva‐based therapeutic drug monitoring of linezolid.

Model‐based dose optimization framework for bedaquiline, pretomanid and linezolid for the treatment of drug‐resistant tuberculosis.

Effect of renal function on the risk of thrombocytopaenia in patients receiving linezolid therapy: A systematic review and meta‐analysis.

Population pharmacokinetics and target attainment analysis of linezolid in multidrug‐resistant tuberculosis patients.

Parametric population pharmacokinetics of linezolid: A systematic review.

Linezolid and the risk of QT interval prolongation: A pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System.

Drug‐induced liver injury associated with pretomanid, bedaquiline, and linezolid: Insights from FAERS database analysis.

Effect of oral linezolid on the pressor response to intravenous tyramine.

Contact CCPL

Patron Login

menu

Search Results

Your Filters

Engage with CCPL

Contact CCPL